Understanding the FDA's Take on Cannabidiol

If you're a cancer patient, you are no stranger to pain or, most likely, to opioids.

One therapy, cannabis, has long been discussed as a legitimate therapeutic alternative — but has been caught up in the debate over its nonmedical “recreational” uses, along with its cousin, cannabidiol (CBD). Regardless of where you may stand on these issues, we are moving forward. The times they are a-changing.

But the reality is more complicated than the soundbites, and the reality is that the situation is very complicated. Nowhere is this more obvious or urgent than when it comes to the role and responsibilities of the Food and Drug Administration and its regulation of CBD.
 
In December of last year, the Agriculture Improvement Act of 2018 (“the Farm Bill”) was signed into law. Among other things, this new law changed certain federal authorities relating to the production and marketing of hemp. These changes include removing hemp from the Controlled Substances Act, which means that it will no longer be an illegal substance under federal law. But just as important for the FDA is what the law didn't change: Congress explicitly preserved the agency's current authority to regulate products containing cannabis or cannabis-derived compounds – such as CBD.

Specifically, it remains unlawful under FDA regulations to market CBD products as (or in) dietary supplements, regardless of whether the substances are hemp-derived. Per the FDA, this is because CBD is an active ingredient in an FDA-approved drug (Epidiolex), and is the subject of substantial clinical investigations. Under the Food, Drug, and Cosmetics Act, it's illegal to introduce drug ingredients like these into dietary supplements. So, Farm Bill or no Farm Bill, the FDA has made it clear that cannabidiol is not a legal dietary supplement.

Per the FDA, “We'll take enforcement action needed to protect public health against companies illegally selling cannabis and cannabis-derived products that can put consumers at risk and are being marketed in violation of the FDA's authorities.”1

 
Sign Up for Our Email Newsletter

RECENT NEWS

World Health Organization: 70 COVID-19 Vaccines Under Development, With 3 In Human Trials

World Health Organization: 70 COVID-19 Vaccines Under Development, With 3 In Human Trials

Peter Pitts on Fox News Channel with Neil Cavuto "World Health Organization: 70 COVID-19 Vaccines Under Development, Wi...  Read more

FDA to Announce Tougher Standards for Coronavirus Vaccine

FDA to Announce Tougher Standards for Coronavirus Vaccine

Cheddar's Hena Doba is joined by Prof. Peter Pitts, Founder of the Center for Medicine in the Public Interest and Former ...  Read more

The Spreading Cancer of Counterfeit Drugs
  • CMPI
  • 10/01/2020 12:00 AM

The Spreading Cancer of Counterfeit Drugs

Just as the coronavirus mutates to survive and thrive, so to do the purveyors of counterfeit medicines -- with their high...  Read more

DRUGWONKS BLOG